IBS Treatment Market Report

Global and China IBS Treatment Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 20, 2022
  • PAGES：143
  • REPORT CODE：GMM1391434
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Irritable bowel syndrome (IBS) is a common disorder that affects the digestive system. IBS is characterized by symptoms such as stomach cramps, bloating, diarrhea, and constipation, which impacts one’s everyday life. Although the cause of IBS is unknown, but few factors that cause IBS are severe infection, inflammation in the intestines, muscle contractions in the intestine, changes in bacteria in the gut, and abnormalities in the nerves.

    Rising prevalence of gastrointestinal diseases and disorder, geriatric population, unhealthy diet, anxiety, depression, and changing lifestyle in Americas are the key drivers of the Americas IBS market.

    This report elaborates on the current development of the IBS Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Nestle (Switzerland)

    • Alfasigma USA, Inc (Italy)

    • AstraZeneca (UK)

    • Takeda Pharmaceutical Company Ltd (Japan)

    • Valeant Pharmaceuticals (Canada)

    • Lexicon Pharmaceuticals, Inc (US)

    • Sebela Pharmaceuticals (Ireland)

    • Ardelyx, Inc (US)

    • Synergy Pharmaceuticals, Inc (US)

    • Allergan Plc (Ireland)

    • Astellas Pharma Inc (Japan)

    • Ipsen (France)

    • RedHill Biopharma Ltd (Israel)

    • Novartis AG (Switzerland)

    • Synthetic Biologics, Inc (US)

    • Probi (Sweden)

    • Innovate Biopharmaceuticals (US)

    • Protagonist Therapeutics Inc (US)

    • Pfizer Inc (US)

    • Sucampo Pharmaceuticals (US)

    • Ironwood Pharmaceuticals, Inc (US)

    • Abbott Laboratories (US)

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • IBS-D

    • IBS-C

    • IBS-M

    Application:

    • Hospitals

    • Clinics

    • Research Laboratories

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 IBS Treatment Industry Overview

      • 1.1.1 IBS Treatment Market Scope and Market Segments

      • 1.1.2 IBS Treatment Industry Characteristics

      • 1.1.3 Global and China IBS Treatment Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China IBS Treatment Production Value and Growth Rate (2017-2028)

    • 1.2 Global IBS Treatment Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 IBS-D

      • 1.2.2 IBS-C

      • 1.2.3 IBS-M

    • 1.3 Global IBS Treatment Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Clinics

      • 1.3.3 Research Laboratories

    • 1.4 Market Analysis by Region

      • 1.4.1 North America IBS Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe IBS Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC IBS Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa IBS Treatment Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global IBS Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global IBS Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China IBS Treatment Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China IBS Treatment Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global IBS Treatment Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 IBS Treatment Industry Porter's Five Forces Model Analysis

      • 2.2.3 IBS Treatment Industry PEST Analysis

    • 2.3 IBS Treatment Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 IBS Treatment Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on IBS Treatment Industry

    Chapter 3 Global and China IBS Treatment Market, by Manufacturer

    • 3.1 Global and China IBS Treatment Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China IBS Treatment Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China IBS Treatment Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China IBS Treatment Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China IBS Treatment Market Top 3 Players

    Chapter 4 Global and China IBS Treatment Market, by Type (2017-2028)

    • 4.1 IBS Treatment Market Trend, by Type

    • 4.2 Global IBS Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global IBS Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global IBS Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global IBS Treatment Price Trend, by Type (2017-2028)

    • 4.3 China IBS Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China IBS Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China IBS Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China IBS Treatment Price Trend, by Type (2017-2028)

    Chapter 5 Global and China IBS Treatment Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global IBS Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global IBS Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global IBS Treatment Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China IBS Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China IBS Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China IBS Treatment Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global IBS Treatment Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China IBS Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America IBS Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe IBS Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC IBS Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa IBS Treatment Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America IBS Treatment Market Analysis

    • 7.1 North America IBS Treatment Market, by Type

    • 7.2 North America IBS Treatment Market, by Application

    • 7.3 North America IBS Treatment Market Analysis and Forecast, by Country

      • 7.3.1 United States IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe IBS Treatment Market Analysis

    • 8.1 Europe IBS Treatment Market, by Type

    • 8.2 Europe IBS Treatment Market, by Application

    • 8.3 Europe IBS Treatment Market Analysis and Forecast, by Country

      • 8.3.1 Germany IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC IBS Treatment Market Analysis

    • 9.1 APAC IBS Treatment Market, by Type

    • 9.2 APAC IBS Treatment Market, by Application

    • 9.3 APAC IBS Treatment Market Analysis and Forecast, by Country

      • 9.3.1 China IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa IBS Treatment Market Analysis

    • 10.1 Latin America, Middle East and Africa IBS Treatment Market, by Type

    • 10.2 Latin America, Middle East and Africa IBS Treatment Market, by Application

    • 10.3 Latin America, Middle East and Africa IBS Treatment Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina IBS Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China IBS Treatment Company Profiles

      • 11.1 Nestle (Switzerland)

        • 11.1.1 Nestle (Switzerland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Nestle (Switzerland) IBS Treatment Product Profiles, Application and Specification

        • 11.1.3 Nestle (Switzerland) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Alfasigma USA, Inc (Italy)

        • 11.2.1 Alfasigma USA, Inc (Italy) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Alfasigma USA, Inc (Italy) IBS Treatment Product Profiles, Application and Specification

        • 11.2.3 Alfasigma USA, Inc (Italy) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 AstraZeneca (UK)

        • 11.3.1 AstraZeneca (UK) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 AstraZeneca (UK) IBS Treatment Product Profiles, Application and Specification

        • 11.3.3 AstraZeneca (UK) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Takeda Pharmaceutical Company Ltd (Japan)

        • 11.4.1 Takeda Pharmaceutical Company Ltd (Japan) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Product Profiles, Application and Specification

        • 11.4.3 Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Valeant Pharmaceuticals (Canada)

        • 11.5.1 Valeant Pharmaceuticals (Canada) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Valeant Pharmaceuticals (Canada) IBS Treatment Product Profiles, Application and Specification

        • 11.5.3 Valeant Pharmaceuticals (Canada) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Lexicon Pharmaceuticals, Inc (US)

        • 11.6.1 Lexicon Pharmaceuticals, Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Lexicon Pharmaceuticals, Inc (US) IBS Treatment Product Profiles, Application and Specification

        • 11.6.3 Lexicon Pharmaceuticals, Inc (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Sebela Pharmaceuticals (Ireland)

        • 11.7.1 Sebela Pharmaceuticals (Ireland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Sebela Pharmaceuticals (Ireland) IBS Treatment Product Profiles, Application and Specification

        • 11.7.3 Sebela Pharmaceuticals (Ireland) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Ardelyx, Inc (US)

        • 11.8.1 Ardelyx, Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Ardelyx, Inc (US) IBS Treatment Product Profiles, Application and Specification

        • 11.8.3 Ardelyx, Inc (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Synergy Pharmaceuticals, Inc (US)

        • 11.9.1 Synergy Pharmaceuticals, Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Synergy Pharmaceuticals, Inc (US) IBS Treatment Product Profiles, Application and Specification

        • 11.9.3 Synergy Pharmaceuticals, Inc (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Allergan Plc (Ireland)

        • 11.10.1 Allergan Plc (Ireland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Allergan Plc (Ireland) IBS Treatment Product Profiles, Application and Specification

        • 11.10.3 Allergan Plc (Ireland) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Astellas Pharma Inc (Japan)

        • 11.11.1 Astellas Pharma Inc (Japan) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Astellas Pharma Inc (Japan) IBS Treatment Product Profiles, Application and Specification

        • 11.11.3 Astellas Pharma Inc (Japan) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Ipsen (France)

        • 11.12.1 Ipsen (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Ipsen (France) IBS Treatment Product Profiles, Application and Specification

        • 11.12.3 Ipsen (France) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 RedHill Biopharma Ltd (Israel)

        • 11.13.1 RedHill Biopharma Ltd (Israel) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 RedHill Biopharma Ltd (Israel) IBS Treatment Product Profiles, Application and Specification

        • 11.13.3 RedHill Biopharma Ltd (Israel) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Novartis AG (Switzerland)

        • 11.14.1 Novartis AG (Switzerland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Novartis AG (Switzerland) IBS Treatment Product Profiles, Application and Specification

        • 11.14.3 Novartis AG (Switzerland) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Synthetic Biologics, Inc (US)

        • 11.15.1 Synthetic Biologics, Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Synthetic Biologics, Inc (US) IBS Treatment Product Profiles, Application and Specification

        • 11.15.3 Synthetic Biologics, Inc (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Probi (Sweden)

        • 11.16.1 Probi (Sweden) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Probi (Sweden) IBS Treatment Product Profiles, Application and Specification

        • 11.16.3 Probi (Sweden) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Innovate Biopharmaceuticals (US)

        • 11.17.1 Innovate Biopharmaceuticals (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Innovate Biopharmaceuticals (US) IBS Treatment Product Profiles, Application and Specification

        • 11.17.3 Innovate Biopharmaceuticals (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 Protagonist Therapeutics Inc (US)

        • 11.18.1 Protagonist Therapeutics Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 Protagonist Therapeutics Inc (US) IBS Treatment Product Profiles, Application and Specification

        • 11.18.3 Protagonist Therapeutics Inc (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.19 Pfizer Inc (US)

        • 11.19.1 Pfizer Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.19.2 Pfizer Inc (US) IBS Treatment Product Profiles, Application and Specification

        • 11.19.3 Pfizer Inc (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.20 Sucampo Pharmaceuticals (US)

        • 11.20.1 Sucampo Pharmaceuticals (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.20.2 Sucampo Pharmaceuticals (US) IBS Treatment Product Profiles, Application and Specification

        • 11.20.3 Sucampo Pharmaceuticals (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.21 Ironwood Pharmaceuticals, Inc (US)

        • 11.21.1 Ironwood Pharmaceuticals, Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.21.2 Ironwood Pharmaceuticals, Inc (US) IBS Treatment Product Profiles, Application and Specification

        • 11.21.3 Ironwood Pharmaceuticals, Inc (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.22 Abbott Laboratories (US)

        • 11.22.1 Abbott Laboratories (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.22.2 Abbott Laboratories (US) IBS Treatment Product Profiles, Application and Specification

        • 11.22.3 Abbott Laboratories (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 IBS Treatment Industry Investment Prospect and Risk Assessment

    • 12.1 IBS Treatment Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 IBS Treatment Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Global IBS Treatment Production Value and Growth Rate (2017-2028)

    • Figure China IBS Treatment Production Value and Growth Rate (2017-2028)

    • Figure Global IBS Treatment Market Size and Growth Rate of IBS-D (2017-2028)

    • Figure Global IBS Treatment Market Size and Growth Rate of IBS-C (2017-2028)

    • Figure Global IBS Treatment Market Size and Growth Rate of IBS-M (2017-2028)

    • Figure Global IBS Treatment Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global IBS Treatment Market Size and Growth Rate of Clinics (2017-2028)

    • Figure Global IBS Treatment Market Size and Growth Rate of Research Laboratories (2017-2028)

    • Figure North America IBS Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe IBS Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC IBS Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa IBS Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global IBS Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China IBS Treatment Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China IBS Treatment Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China IBS Treatment Sales Value, by Manufacturer (2021&2022)

    • Table Global and China IBS Treatment Market Share, by Manufacturer (2021&2022)

    • Figure Global and China IBS Treatment Market Share, by Manufacturer in 2021

    • Figure Global and China IBS Treatment Market Share, by Manufacturer in 2022

    • Table Global IBS Treatment Sales Volume, by Type (2017-2028)

    • Table Global IBS Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Global IBS Treatment Sales Volume Share, by Type (2017-2028)

    • Table Global IBS Treatment Sales Value, by Type (2017-2028)

    • Table Global IBS Treatment Sales Value Share, by Type (2017-2028)

    • Figure Global IBS Treatment Price Trend, by Type (2017-2028)

    • Table China IBS Treatment Sales Volume, by Type (2017-2028)

    • Table China IBS Treatment Sales Volume Share, by Type (2017-2028)

    • Figure China IBS Treatment Sales Volume Share, by Type (2017-2028)

    • Table China IBS Treatment Sales Value, by Type (2017-2028)

    • Table China IBS Treatment Sales Value Share, by Type (2017-2028)

    • Figure China IBS Treatment Price Trend, by Type (2017-2028)

    • Table Global IBS Treatment Sales Volume, by Application (2017-2028)

    • Table Global IBS Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Global IBS Treatment Sales Volume Share, by Application (2017-2028)

    • Table Global IBS Treatment Sales Value, by Application (2017-2028)

    • Table Global IBS Treatment Sales Value Share, by Application (2017-2028)

    • Figure Global IBS Treatment Sales Value Share, by Application (2017-2028)

    • Table China IBS Treatment Sales Volume, by Application (2017-2028)

    • Table China IBS Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China IBS Treatment Sales Volume Share, by Application (2017-2028)

    • Table China IBS Treatment Sales Value, by Application (2017-2028)

    • Table China IBS Treatment Sales Value Share, by Application (2017-2028)

    • Figure China IBS Treatment Sales Value Share, by Application (2017-2028)

    • Figure China IBS Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure North America IBS Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Europe IBS Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure APAC IBS Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa IBS Treatment Production, Import, Consumption and Export (2017-2022)

    • Table North America IBS Treatment Sales Volume, by Type (2017-2028)

    • Table North America IBS Treatment Sales Volume Share, by Type (2017-2028)

    • Figure North America IBS Treatment Sales Volume Share, by Type (2017-2028)

    • Table North America IBS Treatment Sales Volume, by Application (2017-2028)

    • Table North America IBS Treatment Sales Volume Share, by Application (2017-2028)

    • Figure North America IBS Treatment Sales Volume Share, by Application (2017-2028)

    • Figure United States IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure United States IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Canada IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Canada IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Mexico IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Table Europe IBS Treatment Sales Volume, by Type (2017-2028)

    • Table Europe IBS Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Europe IBS Treatment Sales Volume Share, by Type (2017-2028)

    • Table Europe IBS Treatment Sales Volume, by Application (2017-2028)

    • Table Europe IBS Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Europe IBS Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Germany IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Germany IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure UK IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure UK IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure France IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure France IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Italy IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Italy IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Spain IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Spain IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Belgium IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Poland IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Poland IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Russia IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Russia IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Turkey IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Table APAC IBS Treatment Sales Volume, by Type (2017-2028)

    • Table APAC IBS Treatment Sales Volume Share, by Type (2017-2028)

    • Figure APAC IBS Treatment Sales Volume Share, by Type (2017-2028)

    • Table APAC IBS Treatment Sales Volume, by Application (2017-2028)

    • Table APAC IBS Treatment Sales Volume Share, by Application (2017-2028)

    • Figure APAC IBS Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Japan IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Japan IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure India IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure India IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Korea IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa IBS Treatment Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa IBS Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa IBS Treatment Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa IBS Treatment Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa IBS Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa IBS Treatment Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Brazil IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Africa IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Argentina IBS Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina IBS Treatment Sales Value and Growth Rate (2017-2028)

    • Table Nestle (Switzerland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nestle (Switzerland) Product Profiles, Application and Specification

    • Table Nestle (Switzerland) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Alfasigma USA, Inc (Italy) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Alfasigma USA, Inc (Italy) Product Profiles, Application and Specification

    • Table Alfasigma USA, Inc (Italy) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca (UK) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca (UK) Product Profiles, Application and Specification

    • Table AstraZeneca (UK) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Takeda Pharmaceutical Company Ltd (Japan) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takeda Pharmaceutical Company Ltd (Japan) Product Profiles, Application and Specification

    • Table Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Valeant Pharmaceuticals (Canada) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Valeant Pharmaceuticals (Canada) Product Profiles, Application and Specification

    • Table Valeant Pharmaceuticals (Canada) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Lexicon Pharmaceuticals, Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Lexicon Pharmaceuticals, Inc (US) Product Profiles, Application and Specification

    • Table Lexicon Pharmaceuticals, Inc (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sebela Pharmaceuticals (Ireland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sebela Pharmaceuticals (Ireland) Product Profiles, Application and Specification

    • Table Sebela Pharmaceuticals (Ireland) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ardelyx, Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ardelyx, Inc (US) Product Profiles, Application and Specification

    • Table Ardelyx, Inc (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Synergy Pharmaceuticals, Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Synergy Pharmaceuticals, Inc (US) Product Profiles, Application and Specification

    • Table Synergy Pharmaceuticals, Inc (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Allergan Plc (Ireland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Allergan Plc (Ireland) Product Profiles, Application and Specification

    • Table Allergan Plc (Ireland) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharma Inc (Japan) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma Inc (Japan) Product Profiles, Application and Specification

    • Table Astellas Pharma Inc (Japan) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ipsen (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ipsen (France) Product Profiles, Application and Specification

    • Table Ipsen (France) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table RedHill Biopharma Ltd (Israel) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table RedHill Biopharma Ltd (Israel) Product Profiles, Application and Specification

    • Table RedHill Biopharma Ltd (Israel) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG (Switzerland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG (Switzerland) Product Profiles, Application and Specification

    • Table Novartis AG (Switzerland) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Synthetic Biologics, Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Synthetic Biologics, Inc (US) Product Profiles, Application and Specification

    • Table Synthetic Biologics, Inc (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Probi (Sweden) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Probi (Sweden) Product Profiles, Application and Specification

    • Table Probi (Sweden) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Innovate Biopharmaceuticals (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Innovate Biopharmaceuticals (US) Product Profiles, Application and Specification

    • Table Innovate Biopharmaceuticals (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Protagonist Therapeutics Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Protagonist Therapeutics Inc (US) Product Profiles, Application and Specification

    • Table Protagonist Therapeutics Inc (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Inc (US) Product Profiles, Application and Specification

    • Table Pfizer Inc (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sucampo Pharmaceuticals (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sucampo Pharmaceuticals (US) Product Profiles, Application and Specification

    • Table Sucampo Pharmaceuticals (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ironwood Pharmaceuticals, Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ironwood Pharmaceuticals, Inc (US) Product Profiles, Application and Specification

    • Table Ironwood Pharmaceuticals, Inc (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Laboratories (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Laboratories (US) Product Profiles, Application and Specification

    • Table Abbott Laboratories (US) IBS Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US